Accelerate Diagnostics
AXDX
$5.05
Share price
12.98%
Change (1 day)
515.85%
Change (1 year)
Categories
Accelerate Diagnostics (AXDX) - P/B ratio
P/B ratio as of December 2023 : -2.10
According to Accelerate Diagnostics's latest financial reports the company has a price-to-book ratio of -2.10.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Accelerate Diagnostics - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | -7.14 | -31.13% |
| 2021-12-31 | -10.4 | 49.15% |
| 2020-12-31 | -6.95 | -94.45% |
| 2019-12-31 | -125 | -1252.7% |
| 2018-12-31 | 10.9 | -11.1% |
| 2017-12-31 | 12.2 | -10.85% |
| 2016-12-31 | 13.7 | 65.85% |
| 2015-12-31 | 8.27 | -36.29% |
| 2014-12-31 | 13.0 | 6.06% |
| 2013-12-31 | 12.2 | 61.12% |
| 2012-12-31 | 7.60 | 163.35% |
| 2011-12-31 | 2.88 | 35.04% |
| 2010-12-31 | 2.14 | -13.17% |
| 2009-12-31 | 2.46 | -55.19% |
| 2008-12-31 | 5.49 | -47.54% |
| 2007-12-31 | 10.5 | 225.76% |
| 2006-12-31 | 3.21 | -5.53% |
| 2005-12-31 | 3.40 | 82.51% |
| 2004-12-31 | 1.86 | 7.67% |
| 2003-12-31 | 1.73 | 71.5% |
| 2002-12-31 | 1.01 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.20 | -300.20% | 🇺🇸 USA |
 Becton Dickinson BDX | 2.63 | -225.35% | 🇺🇸 USA |
 PerkinElmer
PKI | 1.80 | -185.79% | 🇺🇸 USA |
 Bruker BRKR | 7.65 | -464.90% | 🇺🇸 USA |
 NanoString Technologies NSTG | -0.5535 | -73.61% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 1.07 | -151.17% | 🇺🇸 USA |